Lurasidone for the Treatment of Schizophrenia and Types of Depression

Course overview

Lurasidone is a second-generation antipsychotic approved for schizophrenia and bipolar depression, working through dopamine D2 and serotonin 5-HT2A receptor antagonism to manage mood and psychotic symptoms. It has off-label potential in major depressive disorder with mixed features and generalized anxiety disorder, though more research is needed. Compared to other atypical antipsychotics, lurasidone has a lower risk of metabolic complications, making it preferable for patients at risk for weight gain, diabetes, or dyslipidemia. However, careful monitoring is required due to the possibility of extrapyramidal symptoms (EPS), akathisia, and sedation, and it must be taken with food for proper absorption and treatment efficacy.